|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
|
Cincor Pharma, Inc. (CINC) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
| |
Company
Roster
|
|
Total
Insiders : |
15 |
|
|
|
Total
Direct Shares :
|
3,659,514 |
|
|
Total
Indirect Shares :
|
20,199,947 |
| |
%
Held by Insiders:
|
8.36% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  5am Opportunities I (gp), Llc |
10% Owner |
2023-02-24 |
0 |
2023-02-24 |
0 |
| Sofinnova Venture Partners X, L.p. |
10% Owner |
2023-02-24 |
0 |
2023-02-24 |
0 |
| Freeman Mason |
Chief Medical Officer |
2023-02-24 |
0 |
2023-02-24 |
0 |
| De Garidel Marc |
Chief Executive Officer, Director |
2023-02-24 |
0 |
2022-01-11 |
0 |
| Kalb Michael Wayne |
EVP & Chief Financial Officer |
2023-02-24 |
0 |
2022-11-04 |
0 |
| Pearce Catherine |
Chief Operating Officer |
2023-02-24 |
0 |
2023-02-24 |
0 |
| 5am Opportunities Ii, L.p. |
10% Owner |
2022-08-15 |
0 |
2022-08-15 |
983,656 |
| Healy James |
Director, 10% Owner |
2022-08-11 |
29,411 |
2022-08-11 |
6,000 |
| General Atlantic Genpar (lux) Scsp |
10% Owner |
2022-01-11 |
0 |
2022-08-11 |
4,209,470 |
| General Atlantic (spv) Gp, Llc |
10% Owner |
2022-01-11 |
0 |
2022-08-11 |
4,209,470 |
| Katabi Maha |
10% Owner |
2022-01-11 |
0 |
2022-08-11 |
6,073,949 |
| Parmar Kush |
10% Owner |
2022-01-11 |
0 |
2022-01-11 |
496,323 |
| Coelho Mary Theresa |
EVP CFO & Chief BD Officer |
2022-01-11 |
0 |
2022-01-11 |
100 |
| Sofinnova Capital Ix |
10% Owner |
2022-01-11 |
0 |
2022-08-15 |
4,220,979 |
| Cinrx Pharma, Llc |
10% Owner |
2022-01-11 |
3,630,103 |
|
0 |
|
|
